Richard Pzena's position in Pfizer is currently worth $152M. That's 0.45% of their equity portfolio (49th largest holding). The first Pfizer trade was made in Q4 2014. Since then Richard Pzena bought shares twenty more times and sold shares on 23 occasions. The investor's estimated purchase price is $193M, resulting in a loss of 21%.